Comparison of follicular fluid and serum cytokine concentrations in women undergoing assisted reproductive treatment with GnRH agonist long and antagonist protocols.
BACKGROUND
This study investigated whether follicular fluid (FF) and serum (S) concentrations of cytokines in women undergoing assisted reproductive treatment (ART) were different in GnRH antagonist cycles compared to agonist long ones.


METHODS
A retrospective clinical study was performed at a University ART center. A total of 85 women who underwent ART either with agonist long (n = 34) or antagonist protocol (n = 51) were analyzed. FF and serum samples were collected at the time of oocyte retrieval and measured for interleukin (IL)- 1beta, IL-6, IL-8, IL-12, tumor necrosis factor (TNF)-alpha by the enzyme-linked immunosorbent assay (ELISA) technique, using commercially available kits and nitric oxide (NO) by the nitrate/nitrite colorimetric assay. The results were compared between GnRH antagonist and agonist cycles.


RESULTS
No significant difference was found in the FF concentrations of those cytokines between the two protocols. The serum values were also similar in the two groups except IL-6 (14.3 +/- 4.8 vs. 20.5 +/- 12.2 pg/ml; p = 0.008) and NO (1.4 +/- 1.1 vs. 2.2 +/- 1.9 microm; p = 0.038) levels which were found to be significantly lower in antagonist cycles.


CONCLUSIONS
There is no significant difference in follicular microenvironment in terms of IL-1beta, IL-6, IL-8, IL-12, TNF-alpha, and NO levels between agonist long and antagonist cycles. However, serum IL-6 and NO levels were lower in women given antagonists.
Ficicioglu
Cem
C
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Yeditepe University Hospital, Istanbul, Turkey.
Kumbak
Banu
B
Akcin
Oya
O
Attar
Rukset
R
Yildirim
Gazi
G
Yesildaglar
Narter
N
D000328:Adult; D016207:Cytokines / Q000097:blood*; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage*; D015571:Follicular Fluid / Q000737:chemistry / Q000378:metabolism*; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000819:agonists / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage*; D027724:Reproductive Techniques, Assisted; D012189:Retrospective Studies
D016207:Cytokines; D005300:Fertility Agents, Female; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide; C061018:ganirelix